Nick Kyrgios faces a tribunal ruling on his anti-doping violation after testing positive for a cocaine metabolite from a June 2026 sample at the Mallorca ATP event, triggering a mandatory provisional suspension since August 4. Tennis Anti-Doping Programme rules for substances of abuse allow reduced sanctions—potentially capped at three months—if the use occurred out of competition, while in-competition findings or aggravating factors can extend bans significantly toward the two-to-four-year range. His public admission of a “huge mistake,” lack of appeal to date, and ongoing personal struggles introduce variables around cooperation credit and prior conduct that traders weigh against typical first-offense precedents. With the tribunal outcome still pending and limited public details on timing or evidence thresholds, implied probabilities remain tightly clustered across short, medium, and longer bans as the market reflects unresolved questions over classification and mitigation.